Combining tissue profiling with whole transcriptome spatial analysis and high-plex protein co-detection enables a deeper, more holistic understanding of tissue organization "The continued expansion of ...
Cure51 plans to analyze more than 1,000 tumor samples from exceptional cancer survivors Working alongside more than 50 medical institutions, Cure51 intends to collect and analyze tumor tissues from ...
Drug discovery is becoming more personalized, and the methods used to generate therapeutic insights are advancing alongside it. Spatial biology tools let researchers interrogate tissue function, cell ...
After launching numerous new products for its three platform technologies throughout 2024, 10x Genomics is slowing down its rollouts, focusing instead on marketing its single cell, spatial, and in ...
PARIS and PLEASANTON, Calif., Oct. 31, 2024 /PRNewswire/ -- French TechBio startup Cure51 and 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that Cure51 ...
PLEASANTON, Calif., Feb. 23, 2025 /PRNewswire/ — At the Advances in Genome Biology and Technology (AGBT) General Meeting, 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback